| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Dec'17 |
|---|---|---|---|---|---|---|
ASSETS | ||||||
CURRENT ASSETS | ||||||
Cash and cash equivalents | ||||||
5,930 | 6,995 | - | - | - | 186 | - |
Cash and cash equivalents | ||||||
- | - | 7,382 | 9,363 | 6,048 | - | 1,370 |
Research and development tax credit receivable | ||||||
713 | 568 | 953 | 843 | 605 | 592 | 106 |
Other tax receivable | ||||||
71 | 77 | 105 | 104 | 165 | 37 | 111 |
Joint development cost receivable | ||||||
- | - | - | 49 | 34 | 17 | 109 |
Prepaid expenses | ||||||
266 | 97 | 122 | 200 | 275 | 15 | 42 |
Prepaid expenses - related party | ||||||
- | 26 | 118 | 244 | - | - | 158 |
TOTAL CURRENT ASSETS | ||||||
6,981 | 7,764 | 8,683 | 10,806 | 7,130 | 849 | 1,899 |
Operating lease - right of use asset - related party | ||||||
182 | 191 | 199 | 209 | - | - | - |
Acquired in-process research and development intangible assets | ||||||
16,514 | 16,514 | 16,514 | 16,514 | 16,514 | 16,514 | 16,514 |
TOTAL ASSETS | ||||||
23,677 | 24,470 | 25,396 | 27,529 | 23,644 | 17,363 | 18,413 |
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||
CURRENT LIABILITIES | ||||||
Accounts payable and accrued liabilities | ||||||
695 | 401 | 337 | 438 | 471 | 553 | 126 |
Accounts payable and accrued liabilities - related parties | ||||||
102 | 290 | 162 | 69 | 9 | 270 | 183 |
Deferred grant | ||||||
300 | - | - | - | - | - | - |
Operating lease, current liability - related party | ||||||
18 | 8 | 16 | 7 | - | - | - |
TOTAL CURRENT LIABILITIES | ||||||
1,116 | 700 | 515 | 515 | - | 823 | - |
Long-term operating lease liability - related party | ||||||
154 | 160 | 171 | 177 | - | - | - |
Deferred grant income | ||||||
- | - | - | - | 300 | - | - |
TOTAL LIABILITIES | ||||||
1,271 | 860 | 687 | 692 | 780 | 823 | 309 |
STOCKHOLDERS' EQUITY | ||||||
Common stock, $0.001 par value, 200,000,000 shares authorized, 10,746,948 and 10,770,948 shares issued and outstanding, respectively | ||||||
10 | 10 | 10 | 10 | 9 | 8 | 8 |
Additional paid-in capital | ||||||
45,721 | 44,833 | 43,661 | 42,686 | 33,671 | 25,446 | 19,171 |
Common stock issuable | ||||||
50 | 50 | 50 | 50 | 4,676 | 4,676 | 50 |
Accumulated other comprehensive loss | ||||||
-29 | -8 | -54 | -19 | 5 | 6 | 32 |
Accumulated deficit | ||||||
-23,346 | -21,276 | -18,957 | -15,890 | -15,498 | -13,597 | -1,157 |
TOTAL STOCKHOLDERS' EQUITY | ||||||
22,406 | 23,609 | 24,709 | 26,837 | 22,863 | 16,539 | 18,103 |
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||
23,677 | 24,470 | 25,396 | 27,529 | 23,644 | 17,363 | 18,413 |